Advance notice: NIH SenNet Stage 2 technology projects to study and target senescent cells (UG3/UH3)
NIH plans to release a NOFO for Stage 2 of the SenNet Program to fund Senescence Technology Projects (UG3/UH3). These awards will support tools and computational methods to identify, characterize, and target senescent cells in human tissues to inform senotherapeutics. This is an advance notice; applications are not being accepted yet.
The NIH Common Fund, National Institute on Aging, National Cancer Institute and additional NIH Institutes and Centers (ICs) intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for Stage 2 of the Cellular Senescence Network (SenNet) Program, which seeks to under…
Funding Source
Awards & funding
Eligibility
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers